1K08HS017552-01/HS/AHRQ HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2009	4
2010	4
2011	4
2012	1
2013	3
2014	1
2024	0

1

Preventing and treating biologic-associated opportunistic infections.

Winthrop KL, Chiller T. Winthrop KL, et al. Nat Rev Rheumatol. 2009 Jul;5(7):405-10. doi: 10.1038/nrrheum.2009.105. Nat Rev Rheumatol. 2009. PMID: 19568254 Review.

2

Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy.

Winthrop KL, Chang E, Yamashita S, Iademarco MF, LoBue PA. Winthrop KL, et al. Emerg Infect Dis. 2009 Oct;15(10):1556-61. doi: 10.3201/eid1510.090310. Emerg Infect Dis. 2009. PMID: 19861045 Free PMC article. Review.

3

Rheumatoid arthritis and herpes zoster: risk and prevention in those treated with anti-tumour necrosis factor therapy.

Winthrop KL, Furst DE. Winthrop KL, et al. Ann Rheum Dis. 2010 Oct;69(10):1735-7. doi: 10.1136/ard.2010.133843. Ann Rheum Dis. 2010. PMID: 20858622 No abstract available.

4

Pulmonary disease due to nontuberculous mycobacteria: an epidemiologist's view.

Winthrop KL. Winthrop KL. Future Microbiol. 2010 Mar;5(3):343-5. doi: 10.2217/fmb.10.13. Future Microbiol. 2010. PMID: 20210543 Review. No abstract available.

5

Tuberculosis of the nasolacrimal duct.

Varley CD, Gross ND, Marx DP, Winthrop KL. Varley CD, et al. Ophthalmic Plast Reconstr Surg. 2011 Sep-Oct;27(5):e129-31. doi: 10.1097/IOP.0b013e318201d4fb. Ophthalmic Plast Reconstr Surg. 2011. PMID: 21242852 Review.

6

Mycobacterial diseases and antitumour necrosis factor therapy in USA.

Winthrop KL, Baxter R, Liu L, Varley CD, Curtis JR, Baddley JW, McFarland B, Austin D, Radcliffe L, Suhler E, Choi D, Rosenbaum JT, Herrinton LJ. Winthrop KL, et al. Ann Rheum Dis. 2013 Jan;72(1):37-42. doi: 10.1136/annrheumdis-2011-200690. Epub 2012 Apr 20. Ann Rheum Dis. 2013. PMID: 22523429

7

Distinguishing tuberculosis from nontuberculous mycobacteria lung disease, Oregon, USA.

Kendall BA, Varley CD, Choi D, Cassidy PM, Hedberg K, Ware MA, Winthrop KL. Kendall BA, et al. Emerg Infect Dis. 2011 Mar;17(3):506-9. doi: 10.3201/eid1703.101164. Emerg Infect Dis. 2011. PMID: 21392445 Free PMC article.

8

Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology.

Cassidy PM, Hedberg K, Saulson A, McNelly E, Winthrop KL. Cassidy PM, et al. Clin Infect Dis. 2009 Dec 15;49(12):e124-9. doi: 10.1086/648443. Clin Infect Dis. 2009. PMID: 19911942

9

Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease.

Winthrop KL, McNelley E, Kendall B, Marshall-Olson A, Morris C, Cassidy M, Saulson A, Hedberg K. Winthrop KL, et al. Am J Respir Crit Care Med. 2010 Oct 1;182(7):977-82. doi: 10.1164/rccm.201003-0503OC. Epub 2010 May 27. Am J Respir Crit Care Med. 2010. PMID: 20508209

10

The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy.

Winthrop KL, Baxter R, Liu L, McFarland B, Austin D, Varley C, Radcliffe L, Suhler E, Choi D, Herrinton LJ. Winthrop KL, et al. Pharmacoepidemiol Drug Saf. 2011 Mar;20(3):229-35. doi: 10.1002/pds.2049. Epub 2010 Dec 10. Pharmacoepidemiol Drug Saf. 2011. PMID: 21351303 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year